
Giant cell arteritis Program in Pharmaceutical Benefits Scheme (PBS) 012-19072601

-   Background
-   Process
-   Resources

[Expand/Collapse all sections]Expand all

This document outlines the Pharmaceutical Benefits Scheme (PBS) for
patients with Giant cell arteritis (GCA).

Giant cell arteritis and listing dates

Giant cell arteritis is an inflammation of blood vessels in and around
the scalp.

Listing dates: tocilizumab – 1 August 2019

Note: patients must be aged 50 years or older

Enquiries

Transfer enquiries about prescription arrangements to the PBS Complex
Drugs Programs team and choose the option relevant to the condition
treated.

The Resources page contains links to restriction and item codes, contact
details, application forms, the Pharmaceutical Benefits Scheme (PBS) and
Services Australia websites.

Related links

Written Authority Required Drugs

Processing Written Authority Required Listings

Processing and National Demand Allocation (PaNDA)

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA
System)

                                   

-   Services Australia ABN 90 794 605 008 
